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Candida species are important nosocomial pathogens associated with high mortality rates. Rapid detection
and identification of Candida species can guide a clinician at an early stage to prescribe antifungal drugs or
to adjust empirical therapy when resistant species are isolated. Confocal Raman microspectroscopy is highly
suitable for the rapid identification of Candida species, since Raman spectra can be directly obtained from
microcolonies on a solid culture medium after only 6 h of culturing. In this study, we have used a set of 42
Candida strains comprising five species that are frequently encountered in clinical microbiology to test the
feasibility of the technique for the rapid identification of Candida species. The procedure was started either
from a culture on Sabouraud medium or from a positive vial of an automated blood culture system. Prior to
Raman measurements, strains were subcultured on Sabouraud medium for 6 h to form microcolonies. Using
multivariate statistical analyses, a high prediction accuracy (97 to 100%) was obtained with the Raman
method. Identification with Raman microspectroscopy may therefore be significantly faster than identification
with commercial identification systems that allow various species to be identified and that often require 24 to
48 h before a reliable identification is obtained. We conclude that confocal Raman microspectroscopy offers a
rapid, accurate, and easy-to-use alternative for the identification of clinically relevant Candida species.
Yeasts of the genus Candida are increasingly encountered as
the cause of nosocomial infections. These opportunistic patho-
gens are often isolated from critically ill patients on intensive
care units (ICUs), e.g., patients receiving broad-spectrum an-
timicrobial therapy or patients with intravascular devices (28,
42). Candida species are the fourth most commonly encoun-
tered nosocomial pathogens in bloodstream infections in the
United States, and candidiasis is associated with high mortality
rates (5, 14, 17, 31, 43). Of the Candida species encountered in
clinical practice, Candida albicans is the most prevalent. C.
albicans is often susceptible to the azole group of antifungal
agents. However, there is a shift toward the more azole-toler-
ant species, such as C. glabrata, C. tropicalis, and C. krusei,
possibly related to the increasing use of itraconazole and flu-
conazole, the antifungal drugs of first choice in candidiasis (3,
30, 31, 40, 45). Rapid identification of these species is therefore
relevant for the clinician in determining the correct antifungal
agent.
Conventional identification of Candida species is based on
an extensive series of tests, e.g., carbohydrate fermentation and
assimilation, growth at 37 and 42°C, colony and cell morphol-
ogy, and the ability to form germ tubes (27, 45). Available
commercial yeast identification systems are derived from this
conventional approach, e.g., the Vitek2 system (bioMerieux,
Lyon, France), API 20C (bioMerieux, Basingstoke, United
Kingdom), the RapID Yeast Plus system (Innovative Diagnos-
tic Systems, Norcross, Ga.), and the Minitek system (Becton
Dickinson Microbiology Systems, Cockeysville, Md.). The per-
formance of commercial identification systems has been exten-
sively evaluated for most clinically relevant Candida species.
Once enough biomass was obtained from the initial culture (16
to 24 h for most commonly encountered species), results were
obtained after 4 h to several days of incubation, depending on
the system. Identification accuracy was reported to be between
59 and 99% and seemed to improve with an increase in the
number of tests included in the system (10, 11, 19, 27, 33, 41,
44–46). Most of the rapid (same-day) identification systems are
designed to discriminate between two species or to confirm a
presumptive identification. Rapid systems enabling identifica-
tion of various species are at best limited to the more common
species seen in the clinical laboratory (45). Therefore, the need
for rapid multispecies tests still exists.
Rapid identification of microorganisms in general has been
shown to have a major impact on the morbidity, mortality, and
duration of hospitalization (2, 7, 16). Doern and coworkers
showed that when an empirically started antimicrobial therapy
had to be changed based on laboratory results, this change
could be made ca. 15 h earlier when rapid techniques were
applied (7). For Candida species involved in bloodstream in-
fections on ICUs, it was shown by Ibrahim et al. that initial
therapy was inadequate in 95% of the cases because no anti-
fungal agent was included (16). Due to the inadequacy of the
initial therapy, a mortality rate of about 60% was observed in
the patient group with Candida infections. Hence, early recog-
nition of a Candida infection would help a clinician to select
proper treatment. Combined with rapid identification of the
causative organism, this treatment could be optimized, if re-
quired, at an early stage of the infection.
Vibrational spectroscopic techniques are highly suitable as a
basis for the development of rapid identification methods.
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Fourier transform infrared (FT-IR) spectroscopy and Raman
spectroscopy provide information about the molecular compo-
sition of a sample. The overall molecular compositions of mi-
crobial species and strains are sufficiently different to lead to
reproducible differences in FT-IR and Raman spectra, to the
extent that the spectra can be used as highly specific spectro-
scopic fingerprints to enable the identification of microorgan-
isms (6, 8, 9, 12, 13, 15, 22, 25, 26). Recently, a new and rapid
method “for recording” Raman spectra of microbial micro-
colonies directly on solid culture media was reported (23).
Reproducible Raman spectra can be obtained from microcolo-
nies 10 to 100 m in diameter, such as will develop for most
commonly encountered microorganisms after about 6 h of
culturing (4, 23). A good impression of the potential identifi-
cation accuracy of Raman spectroscopy-based methods was
obtained from a comparison of vibrational spectroscopic meth-
ods with genotypic identification methods. Raman spectra
were obtained from dried smears on glass slides of overnight
cultures of Enterococcus species. A cluster analysis carried out
on the Raman database thus established showed that cluster-
ing of strains occurred in accordance with genotypic species
identification, whereas routine phenotypic methods failed in a
number of cases (20).
Here we present the results from a study aimed at the de-
velopment of a rapid and accurate identification method for
clinically relevant Candida species. An identification algorithm
is described and tested which carries out Candida species iden-
tification based on Raman spectra obtained from 6-h micro-
colonies on a solid culture medium, with or without prior
passage through a blood culture system.
MATERIALS AND METHODS
Yeast strains and identification. A collection of 42 Candida strains was used
(Table 1). Strains either were obtained from culture collections (American Type
Culture Collection, Manassas, Va.: C. albicans ATCC 90028, C. glabrata ATCC
66032, C. kefyr ATCC 66028, and C. tropicalis ATCC 750; Centraalbureau voor
Schimmelcultures, Utrecht, The Netherlands: C. krusei CBS 573) or were clinical
isolates identified to the species level by the conventional identification methods
mentioned above.
Sample preparation. Samples were stored at 80°C in brain heart infusion
broth (Becton Dickinson, Franklin Lakes, N.J.) containing 10% glycerol until
use. Thirty-two strains were subcultured on Sabouraud–2% glucose (SAB) me-
dium for 6 h at 30°C prior to Raman measurements of microcolonies following
overnight passage (30°C) on SAB medium (Merck, Darmstadt, Germany). The
data set of spectra obtained from microcolonies prepared in this way is referred
to as the SAB data set.
For 34 strains (Table 1), microcolonies were prepared after passage through a
blood culture system in order to determine if this process would affect the
identification ability of the Raman method. The strains were seeded at 103
CFU/ml in 10 ml of blood from healthy volunteers. The seeded blood samples
were used to inoculate mycosis culture vials of the automated BACTEC blood
culture system (Becton Dickinson). When the culture vials were flagged as
positive by the system (within 24 h for most strains), several drops of the liquid
culture medium were plated on SAB medium and cultured for 6 h at 30°C prior
to Raman measurements of microcolonies. The data obtained from samples
precultured in the BACTEC system are referred to as the blood data set.
Confocal Raman microspectroscopy. Raman spectroscopic measurements
were performed as described previously (23). Briefly, the solid culture medium
containing the microcolonies was placed directly under the microscope of a
system 1000 Raman microspectrometer (Renishaw plc, Wotton-under-Edge,
Gloucestershire, United Kingdom). The microscope was fitted with a 80 near-
infrared objective (MIR Plan 80/0.75; Olympus). Samples were excited by using
100 to 150 mW of 830-nm laser light from a titanium-sapphire laser (model 3900;
Spectra Physics, Mountain View, Calif.) pumped by an argon ion laser (series
2000; Spectra Physics). The constant background signal contribution originating
from optical elements in the laser light delivery pathway was subtracted from all
spectra. The reference spectrum of a tungsten band lamp of known temperature
was used to correct for the wavelength-dependent signal detection efficiency of
the Raman setup (29, 47). Calibration of the wave number axis was performed by
using the known wavelengths of the atomic lines from neon and argon.
For each yeast sample, five microcolonies were selected. Within each micro-
colony, spectra were obtained from 10 randomly chosen locations by using a
signal collection time of 30 s per measurement. For each sample measured, the
50 spectra thus obtained were averaged. The yeast Raman spectra used for this
study were obtained over a 3-month period.
Sixty Raman spectra for SAB medium were obtained at random locations in
the medium over 30 min of signal collection time. Sixty water spectra were also
obtained over 30 min of total signal collection time.
Spectrum treatment. All spectrum analyses were performed on first deriva-
tives of the measured spectra. This was done in order to minimize the influence
of the broad, relatively featureless signal background usually ascribed to fluo-
rescence, on which the Raman spectra are superimposed and which may vary
from sample to sample (23).
In an earlier study (23), a method was described for orthogonalizing microbial
signal contributions to the background signal contribution of the solid culture
medium. This procedure is necessary because the actual signal contribution of
the culture medium critically depends on the exact position of the laser focus in
the colony and therefore unavoidably varies from one measurement to the next.
After the orthogonalizing procedure, Raman spectra obtained from a particular
microcolony look the same, irrespective of the intensity of the culture medium
signal contribution initially present. Collection of a database of spectra over an
extended period of time necessitates the use of culture plates from different
batches, which will show slight variations in composition and water concentra-
tion. Moreover, inhomogeneities within one culture plate can be encountered at
the microscopic scale at which the Raman experiments take place. This means
that in order for all spectra of yeast microcolonies to be compared, they must be
orthogonalized with respect to all culture medium spectra. In the earlier study,
this goal was accomplished by sequentially orthogonalizing a spectrum to all
medium spectra (23). Here we have applied a more efficient method. The spectra
of all the culture plates and of water were subjected to principal-component (PC)
analysis (PCA). The first PCs, accounting for 99% of all signal variance within
this data set of spectra, were used to construct a PC subspace. Microcolony
spectra were projected onto this PC subspace, and only the spectrum component
orthogonal to this PC subspace was retained for further analysis. After this
procedure, microcolony spectra are obtained that are both independent of the
amount of medium signal contribution originally present and independent of
batch-to-batch variations in medium composition (unless these affect the bio-
chemical composition of the cells, e.g., due to effects on growth rate [23]).
All procedures used for spectrum treatment and data analysis were developed
by using the Matlab 5.3 software package (The Mathworks Inc., Natick, Mass.)
and the multivariate statistical analysis toolbox PLS-toolbox 2.0.0c (Eigenvector
Research Inc., Manson, Wash.) unless otherwise stated.
Data analysis. (i) PCA. Before multivariate statistical analyses, a data reduc-
tion was performed by using PCA; this is a well-known method for reducing the
dimensionality in a data set (18, 35). The maximum number of n  1 PCs was
calculated (n being the number of spectra in the analysis), typically accounting
for 99 to 100% of the variation in the data set.
(ii) HCA. Hierarchical cluster analysis (HCA) was performed on the n  1 PC
scores obtained for each spectrum by using Ward’s clustering algorithm and the
squared Euclidean distance measure to generate a dendrogram. For HCA, the
SPSS (Chicago, Ill.) statistical software package was used.
(iii) LDA. For linear discriminant analysis (LDA), only PC scores accounting
for more than 1% of the variance in the data set were retained. A two-sided t test
was used to individually select PC scores that showed the highest significance in
discriminating the different microbial groups presented. The number of PC
scores that was used as an input for an LDA model was kept at least two times
smaller than the number of spectra in the smallest model group to prevent
overfitting in the LDA model (1).
RESULTS AND DISCUSSION
Our aim in this study was to develop a rapid identification
scheme for clinically relevant Candida species based on con-
focal Raman microspectroscopy. From earlier studies, we
learned that reproducible Raman spectra can be obtained from
microbial microcolonies still growing on a solid culture me-
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dium (4, 23). Figure 1 shows typical Raman spectra from the
five different Candida species included in this study. The high-
lighted spectral features show characteristic differences be-
tween the different species. The differences, from species to
species, in the relative heights of these bands are believed to be
due to differences in the biochemical compositions of the cell
walls. A precise band assignment is the subject of further
investigation.
HCA is a nonsupervised method for obtaining information
about the dissimilarity between spectra of different species.
Figure 2 shows the dendrogram resulting from HCA per-
formed on the Raman spectra in the SAB data set (i.e., spectra
obtained from strains cultured on Sabouraud medium only; see
Materials and Methods). Separate clusters were formed for the
species, with the exception of C. krusei, the spectra of which
were distributed between two clusters. One strain, C. krusei 4,
TABLE 1. Composition of the strain collection used in this study
Species Straina
Member of the
following data setb: Originc Identificationmethodd Reference or source
SAB Blood
C. albicans 2 x Blood CA 41
3 x x Blood CA 41
11 x Blood CA 41
12 x x Blood CA 41
25 x Blood CA 41
42 x x Tissue CA 41
6319 x x Oral cavity GT, CS 39
ATCC 28367 x x
ATCC 38696 x x
ATCC 90028 x x
C. glabrata 32 x Blood CA 41
37 x x Blood CA 41
46 x x Blood CA 41
326 I/95 x Stomach biopsy API ID 32C D. Naumanne
33371 I/94 x Oral swab API ID 32C D. Naumann
ATCC 66032 x
ATCC 90030 x
C. kefyr 13 x x Blood CA 41
29 x x Tissue CA 41
52 x x Feces CA 41
53 x x Oral rinse CA 41
146 I/96 x BAL API ID 32C D. Naumann
430 II/96 x BAL API ID 32C D. Naumann
ATCC 66028 x x
C. krusei 4 x Tissue CA 41
7 x x Blood CA 41
8 x x Sputum CA 41
10 x x Tissue CA 41
14 x BAL CA 41
15 x x Tissue CA 41
28 x Oral rinse CA 41
40 x x Tissue CA 41
47 x x Tissue CA 41
CBS 573 x x
C. tropicalis 19 x x Blood CA 41
45 x x Ascites fluid CA 41
48 x x Tissue CA 41
326 II/95 x Stomach biopsy API ID 32C D. Naumann
ATCC 750 x
M38 I/96 x Oral rinse API ID 32C D. Naumann
M56 I/93 x Sputum API ID 32C D. Naumann
M675 I/93 x Blood API ID 32C D. Naumann
Total (n) 42 32 34
a ATCC, American Type Culture Collection; CBS, Centraal bureau voor Schimmelcultures.
b Strains in the SAB data set were only cultured on Sabouraud medium; strains in the blood data set were obtained from spiked blood cultures (see Materials and
Methods for details). x, a Raman spectrum of the strain is included.
c BAL, bronchoalveolar lavage.
d CA, assimilation of carbohydrates; GT, germ tube formation in human serum; CS, chlamydospore formation on cornmeal agar. The API ID 32C was from
bioMerieux, Lyon, France.
e The strain was kindly provided by the laboratory of D. Naumann, Robert Koch Institute, Berlin, Germany.
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was grouped in the C. glabrata cluster by using this objective
approach. The spectral differences observed between the av-
eraged spectra of the two C. krusei clusters were only very
minor and could not be attributed to specific molecular frac-
tions (Fig. 3). As explained in Materials and Methods, HCA
uses squared Euclidean distances between spectra as input
parameters. The results that we obtained show that this mea-
sure of overall signal variance encountered within a set of
spectra obtained from different strains belonging to the same
species can be as large as the interspecies signal variance. In
order to facilitate species identification, it is necessary there-
fore to apply supervised analysis methods, which look for the
signal variance that is relevant to species discrimination. Here
we used the results of the HCA method as a first step in
developing a sequential species identification scheme based on
LDA.
LDA was applied to the PC scores that were most informa-
tive for the separation of the different species involved. In
order to reduce the complexity of the LDA model used, a
method was chosen in which the Candida species were sepa-
rated at different levels. The use of different levels in a sequen-
tial approach to separate microorganisms based on FT-IR was
described earlier by Udelhoven et al. (38). For preparing the
models in this study, the similarity between the species, as
observed in the HCA, was used to distinguish the different
levels (Fig. 4). Model 1 separates C. albicans, C. tropicalis, and
C. kefyr from C. krusei and C. glabrata. This distinction is based
on the largest dissimilarity observed. Model 2 discriminates
between C. albicans or C. tropicalis and C. kefyr. Model 3 is
designed to discriminate between C. krusei and C. glabrata.
Finally, model 4 further separates C. albicans and C. tropicalis.
Based on the outcome of model 1, an unknown spectrum is
projected on either model 2 or model 3. When model 2 pre-
dicts the Raman spectrum as belonging to either C. albicans or
C. tropicalis, the spectrum is finally projected on model 4 to
distinguish between these species.
The prediction accuracy of the identification model was de-
termined by using a “leave-one-out” evaluation (34). The spec-
tra of all but one strain were used to generate LDA models 1
to 4. For strains that were included in both the SAB data set
and the blood data set, both spectra were left out. The spec-
trum or spectra that were left out were used to test the accu-
racy of the identification model. By repeating this procedure
and leaving the spectrum or spectra of each strain out in turn,
information was obtained on the reproducibility of the identi-
fication procedure, i.e., if there was enough discriminating
information in the Raman spectra to identify unknown spectra
correctly. When the “leave-one-strain-out” evaluation was per-
formed on the SAB data set, all 32 strains (100%) were cor-
rectly identified (Table 2). This result indicates that although
HCA showed two separate C. krusei clusters and one misclas-
sification, a supervised method was able to identify character-
istic spectral differences between C. krusei and C. glabrata
which otherwise remain hidden in non-species-specific signal
FIG. 1. Representative Raman spectra of five Candida species used in this study. Spectra are averages of those obtained from the SAB data
set. Broken lines indicate spectral features of which the relative intensities differ between the spectra of different species. a.u, arbitrary units.
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variance. Furthermore, performing the leave-one-strain-out
evaluation with the SAB data set and the blood data set com-
bined again yielded a high prediction accuracy of 97.0% (Table
3). Two strains from the blood data set were misidentified: C.
tropicalis 40 was predicted to be C. albicans, and C. krusei M38
I/96 was identified as C. glabrata. Taking the results of the
combined data set into account, there were no significant dif-
ferences in identification accuracy between the SAB data set
and the blood data set. This result indicates that pretreatment
or culturing of the Candida strains prior to Raman measure-
ments did not significantly influence the accuracy of the LDA
model used. Therefore, considering the speed and ease at
which various species can be identified, confocal Raman mi-
crospectroscopy has the potential to develop into a more pow-
erful and faster technique than the rapid identification systems
available today.
Vibrational spectroscopic techniques have been used by sev-
eral authors to study Candida species (21, 22, 32, 35–38). To
our knowledge, however, this is the first time that confocal
Raman microspectroscopy has been used for identification
purposes. Performing measurements directly with microcolo-
nies on solid culture medium has several advantages in a clin-
ical diagnostic setting. The most obvious advantage is the short
time required for obtaining microcolonies with which measure-
ments can be performed. Furthermore, besides the minimal
sample processing required, there is no need to use labels or
dyes, and there is only a limited need for disposable supplies.
A known problem with Candida infections on ICUs is that
therapy is started relatively late, because of the lack of early
clinical manifestations and the delay in laboratory detection
procedures. Consequently, Candida infections are associated
with high mortality rates (24). The results presented here show
that high prediction accuracy could be achieved within 6 h after
a sample was cultured on SAB medium or when blood cultures
became positive. In our routine microbiological laboratory,
positive BACTEC cultures due to a Candida infection are
analyzed by using the Vitek2 system. After the BACTEC cul-
ture vials are flagged as positive by the system, an additional 24
to 48 h is required for identification. Rapid recognition of a
species with a possible tolerance toward azole agents (C. gla-
brata, C. tropicalis, and C. krusei) presents the clinician with an
FIG. 2. Dendrogram resulting from HCA of Raman spectra of
Candida strains in the SAB data set (see Materials and Methods). The
squared Euclidean distance measure and Ward’s clustering algorithm
were used in the analysis. CAL, C. albicans; CGL, C. glabrata; CKE, C.
kefyr; CKR, C. krusei; CTR, C. tropicalis; a.u, arbitrary units.
FIG. 3. Raman spectra arising from the averages of C. krusei clus-
ter 1 (strains 28, 40, and 47) and C. krusei cluster 2 (strains 7, 8, 10 14,
15, and CBS 573) as shown in Fig. 1. The difference spectrum at the
bottom shows the spectral differences between cluster 1 and cluster
2. a.u, arbitrary units.
FIG. 4. Schematic representation of the sequential identification
procedure based on LDA models 1 to 4. Spectra to be identified are
predicted by using model 1; depending on the result, the next projec-
tion will be on model 2 or 3, and so forth. Models are produced based
on the major groupings found in the dendrogram of Fig. 2.
TABLE 2. Results of the leave-one-strain-out evaluation with
the SAB data set
Species
No. of strains with the following Raman identification:
C. albicans C. tropicalis C. kefyr C. krusei C. glabrata Total
C. albicans 10 10
C. tropicalis 3 3
C. kefyr 5 5
C. krusei 10 10
C. glabrata 4 4
Total 10 3 5 10 4 32
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option to monitor very closely the effect of treatment with such
an antifungal agent or to choose a different agent at an early
stage of the infection. Our current aim is to use Raman iden-
tification in a prospective study of blood cultures in our tertiary
care hospital. We conclude that confocal Raman microspec-
troscopy may offer a rapid, accurate, and easy-to-use alterna-
tive for the identification of clinically relevant Candida species.
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